Receptor-interacting protein kinase1 (RIPK1) is a central regulator of cell death pathways, including apoptosis, necroptosis, and inflammation (Ofengeim et al., 2017)
Clouded by the fact that patients may have signs of more than one rosacea subtype at the same time and signs and symptoms vary from patient to patient, dermatologists have to consider all groups --- visually because there is no specific test for rosacea to guide them so it would not be unusual for the doctor to order tests to rule out other conditions that look similar to rosacea
JAD 63, 13371346
These conditions and causes include emphysema, asthma, allergic disorders, drug toxicity, metabolic disorders, cancer, chemotherapy and human immunodeficiency virus-acquired immune deficiency syndrome, among others
In some embodiments, the otic formulation or composition comprises between about 1% to about 10% by weight of the therapeutic agent, or pharmaceutically acceptable prodrug or salt thereof
